Testing the Interplay of Gambling, Emotion and Reward

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorHôpital le Vinatier

About this trial

Background The nature and direction of dysfunctional reward processing in gambling disorder remains unclear. We aim to test a novel neurobiological model of gambling addiction, that takes into account inter-individual differences, as well as the multifactorial nature of gaming addiction.

Objectives

Primary objective:

This project will test the hypothesis that there are two opposite brain phenotypes that characterize two distinct subpopulations of gamblers, so-called impulsive vs. emotional, respectively.

Secondary objective:

This project will also seek to determine whether the brain phenotypes proposed above are capable of predicting gambling behavior outside the laboratory.

Study design The primary objective will be tested using a reward task and a facial emotion recognition task performed by participants in an fMRI scanner.

The secondary objective will be tested by combining fMRI measures with behavioral measures from everyday life collected via Ecological Momentary Assessment (EMA).

Study population This study will focus on individuals with gambling problems, as well healthy subjects with no gambling problems and no psychiatric comorbidities.

Outcomes/Endpoints

Primary endpoint:

We will compare striatum and amygdala reactivity between the three groups of impulsive gamblers, emotional gamblers and healthy subjects.

Secondary endpoint:

We will assess the correlation between emotional states and gambling behavior in everyday life, based on striatum and amygdala reactivity, using multiple linear regression models.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Aged between 18 and 65

Fluent French, read and spoken

Male and Female

Informed consent to take part in the research

Disqualifiers

Contra-indication to MRI

Protected Adults

Breast feeding or pregnant women

Neurological disorder or severe chronic illness (diabetes, heart disease, kidney disease, lung disease or liver disease, inflammatory disease….)

Trial population

Two groups: 60 individuals with gambling problems (i.e. Number of DSM-5 critera for gambling disorder ≥3) and 60 matched healthy controls

Trial design

Design model

Case-control

Time perspective

Cross-sectional

Treatments tested in this trial

  • fMRI

    Other intervention

    A brain imaging technique that measures in vivo the activity of brain areas by detecting local changes in blood flow.

  • Ecological Momentary Assessment

    Other intervention

    studies people's thoughts and behaviour in their daily lives by repeatedly collecting data in an individual's normal environment, at or close to the time they carry out that behaviour

Treatment groups

120 Participants
are divided into 2 treatment groups
Group A: Individuals with gambling problems2 interventions
Group B: Healthy control individuals1 intervention

Trial outcomes

Primary outcomes

1

Striatal BOLD response to reward outcomes and amygdala BOLD response to emotional stimuli

Striatal BOLD response: average BOLD signal as measured with fMRI in the striatum in response to monetary reward outcomes in a gambling task. amygdala BOLD response: average BOLD signal as measured with fMRI in the amygdala in response to emotional faces in a facial emotion recognition task.

Time frame
4 weeks

Secondary outcomes

1

Correlation between emotional states and gambling behavior in everyday life

Emotions and gambling behavior in everyday life will be measured using Ecological Momentary Assessment on gamblers' smartphones

Time frame
4 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Hôpital le Vinatier

Lead sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Collaborator